Company Filing History:
3 out of 366 
1 out of 1 
1 out of 832,812 Years Active: 2000-2007
Title: The Innovative Contributions of Andrew I Lazarovits
Introduction
Andrew I Lazarovits is a notable inventor based in London, Canada. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 5 patents, Lazarovits has focused on advancing therapies for transplant rejection and autoimmune diseases.
Latest Patents
Among his latest patents is a method for the prevention or reversal of transplant rejection, which utilizes anti-CD45 leukocyte antigen antibodies for immunomodulation. This method involves administering compounds such as monoclonal antibodies that specifically bind to preselected CD45R leukocyte antigens, including the CD45RB epitope. This innovative approach aims to enhance therapeutic options for patients facing transplant challenges and autoimmune disorders.
Career Highlights
Lazarovits has worked with several prominent organizations throughout his career. Notably, he has been associated with Research Corporation Technologies, Inc. and Alimunne, L.L.C. His work in these companies has allowed him to develop and refine his groundbreaking ideas in immunology.
Collaborations
One of his notable collaborators is Sibrand Poppema. Their partnership has contributed to the advancement of research in the field, further enhancing the impact of Lazarovits' inventions.
Conclusion
Andrew I Lazarovits stands out as an influential inventor in the realm of immunology. His innovative patents and collaborations have paved the way for new therapeutic strategies in managing transplant rejection and autoimmune diseases. His contributions continue to inspire advancements in medical science.